These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28634045)

  • 1. EGFR/EGFRvIII remodels the cytoskeleton via epigenetic silencing of AJAP1 in glioma cells.
    Yang C; Li YS; Wang QX; Huang K; Wei JW; Wang YF; Zhou JH; Yi KK; Zhang KL; Zhou BC; Liu C; Zeng L; Kang CS
    Cancer Lett; 2017 Sep; 403():119-127. PubMed ID: 28634045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AJAP1 is dysregulated at an early stage of gliomagenesis and suppresses invasion through cytoskeleton reorganization.
    Han L; Zhang KL; Zhang JX; Zeng L; Di CH; Fee BE; Rivas M; Bao ZS; Jiang T; Bigner D; Kang CS; Adamson DC
    CNS Neurosci Ther; 2014 May; 20(5):429-37. PubMed ID: 24483339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of LN-308 glioma cell proliferation and migration by retinoic acid amide through activation of Akt pathway.
    Zhu J; Lu XD; Si F; Song CY; Meng QH
    Int J Clin Exp Pathol; 2015; 8(11):13921-7. PubMed ID: 26823704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.
    Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H
    Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR/c-myc axis regulates TGFβ/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas.
    Zhao K; Wang Q; Wang Y; Huang K; Yang C; Li Y; Yi K; Kang C
    Cancer Lett; 2017 Oct; 406():12-21. PubMed ID: 28778566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma.
    Wang FY; Kang CS; Wang-Gou SY; Huang CH; Feng CY; Li XJ
    Cancer Lett; 2017 Jan; 384():9-18. PubMed ID: 27725228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.
    Eskilsson E; Rosland GV; Talasila KM; Knappskog S; Keunen O; Sottoriva A; Foerster S; Solecki G; Taxt T; Jirik R; Fritah S; Harter PN; Välk K; Al Hossain J; Joseph JV; Jahedi R; Saed HS; Piccirillo SG; Spiteri I; Leiss L; Euskirchen P; Graziani G; Daubon T; Lund-Johansen M; Enger PØ; Winkler F; Ritter CA; Niclou SP; Watts C; Bjerkvig R; Miletic H
    Neuro Oncol; 2016 Dec; 18(12):1644-1655. PubMed ID: 27286795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survival.
    Di C; Mladkova N; Lin J; Fee B; Rivas M; Chunsheng K; Bigner D; Adamson DC
    Int J Oncol; 2018 Jan; 52(1):47-54. PubMed ID: 29115565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
    Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
    Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
    Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
    Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma.
    Guillamo JS; de Boüard S; Valable S; Marteau L; Leuraud P; Marie Y; Poupon MF; Parienti JJ; Raymond E; Peschanski M
    Clin Cancer Res; 2009 Jun; 15(11):3697-704. PubMed ID: 19435839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures.
    Narayan RS; Fedrigo CA; Brands E; Dik R; Stalpers LJ; Baumert BG; Slotman BJ; Westerman BA; Peters GJ; Sminia P
    BMC Cancer; 2017 Mar; 17(1):204. PubMed ID: 28320338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of epidermal growth factor receptor and phosphatase and tensin homologue gene expression on the inhibition of U87MG glioblastoma cell proliferation induced by protein kinase inhibitors.
    Xing WJ; Zou Y; Han QL; Dong YC; Deng ZL; Lv XH; Jiang T; Ren H
    Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):13-21. PubMed ID: 23110505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
    Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H
    Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma.
    Zhang J; Zhang J; Qiu W; Zhang J; Li Y; Kong E; Lu A; Xu J; Lu X
    J Neurooncol; 2018 Sep; 139(3):547-562. PubMed ID: 29774498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma.
    Lin N; Di C; Bortoff K; Fu J; Truszkowski P; Killela P; Duncan C; McLendon R; Bigner D; Gregory S; Adamson DC
    Mol Cancer Res; 2012 Feb; 10(2):208-17. PubMed ID: 22241217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway.
    Sun D; Sawada A; Nakashima M; Kobayashi T; Ogawa O; Matsui Y
    Urol Oncol; 2015 Mar; 33(3):111.e17-26. PubMed ID: 25499922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.